Main > ONCOLOGY (**) > Lymphoma>HL>Classical>auto-HSCT>R** > Treatment > Co: USA. S. Brentuximab Vedotin>

---

Co: USA. S. Brentuximab Vedotin>'s subsections
(*) USA Approval Date: 2015. 08.17
>for Inj.
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 6
Patent>UpDate: 2011. 10.25.
TradeMark
TradeMark Web-Site

Co: USA. S. Brentuximab Vedotin>'s products
This section has no products